FR16C0003I1 - - Google Patents
Info
- Publication number
- FR16C0003I1 FR16C0003I1 FR16C0003C FR16C0003I1 FR 16C0003 I1 FR16C0003 I1 FR 16C0003I1 FR 16C0003 C FR16C0003 C FR 16C0003C FR 16C0003 I1 FR16C0003 I1 FR 16C0003I1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
- C07C69/618—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety having unsaturation outside the six-membered aromatic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38493595A | 1995-02-07 | 1995-02-07 | |
PCT/US1996/000940 WO1996024571A1 (en) | 1995-02-07 | 1996-02-06 | Triglycerides and ethyl esters of phenylalkanoic acid and phenylalkenoic acid useful in treatment of various disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
FR16C0003I1 true FR16C0003I1 (pm) | 2016-03-25 |
FR16C0003I2 FR16C0003I2 (fr) | 2016-06-24 |
Family
ID=23519346
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR16C0003C Active FR16C0003I2 (fr) | 1995-02-07 | 2016-02-03 | Triglycerides et esters ethyliques d'acides phenylalcanoiques et phenylalcenoiques utiles dans le traitement de differents troubles |
Country Status (9)
Country | Link |
---|---|
US (3) | US5968979A (pm) |
EP (1) | EP0858441B1 (pm) |
AT (1) | ATE201013T1 (pm) |
AU (1) | AU4858796A (pm) |
CA (1) | CA2212047C (pm) |
DE (1) | DE69612755T2 (pm) |
ES (1) | ES2157422T3 (pm) |
FR (1) | FR16C0003I2 (pm) |
WO (1) | WO1996024571A1 (pm) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6642543B1 (en) | 2000-09-26 | 2003-11-04 | The Board Of Trustees Of The Leland Stanford Junior University | Thin and thick gate oxide transistors on a functional block of a CMOS circuit residing within the core of an IC chip |
US7314953B2 (en) * | 2001-03-27 | 2008-01-01 | Errant Gene Therapeutics, Llc | Treatment of lung cells with histone deacetylase inhibitors |
US7842727B2 (en) | 2001-03-27 | 2010-11-30 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
US7312247B2 (en) | 2001-03-27 | 2007-12-25 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
US8026280B2 (en) | 2001-03-27 | 2011-09-27 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
US6495719B2 (en) | 2001-03-27 | 2002-12-17 | Circagen Pharmaceutical | Histone deacetylase inhibitors |
US20040229948A1 (en) * | 2002-04-12 | 2004-11-18 | Summar Marshall L. | Method for preventing hepatic encephalopathic episodes |
US20030195255A1 (en) * | 2002-04-12 | 2003-10-16 | Summar Marshall L. | Method for treating hepatic encephalopathies |
WO2003099272A1 (en) | 2002-05-22 | 2003-12-04 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors based on alpha-ketoepoxide compounds |
US20090260743A1 (en) * | 2003-11-21 | 2009-10-22 | William David Mawby | Tire manufacturing method for improving the uniformity of a tire |
US20060160902A1 (en) * | 2004-11-08 | 2006-07-20 | Wiech Norbert L | Histone deacetylase inhibitors |
DK2330892T3 (en) | 2008-04-29 | 2016-08-22 | Horizon Therapeutics Inc | METHODS OF TREATMENT WITH USE OF AMMONIAK COLLECTIVE MEDICINES |
HUE040503T2 (hu) * | 2008-08-29 | 2019-03-28 | Horizon Therapeutics Llc | Kezelési eljárások ammónia-leválasztó gyógyszerek használatával |
CA2850391A1 (en) | 2011-09-30 | 2013-04-04 | Hyperion Therapeutics, Inc. | Methods of therapeutic monitoring of nitrogen scavenging drugs |
CN104540507A (zh) | 2012-04-20 | 2015-04-22 | 海波龙治疗公司 | 苯乙酸前药的治疗性监测方法 |
HK1210699A1 (en) | 2012-11-21 | 2016-05-06 | Horizon Therapeutics, Inc. | Methods of administering and evaluating nitrogen scavenging drugs for the treatment of hepatic encephalopathy |
LT2986325T (lt) | 2013-10-14 | 2019-10-10 | Immedica Pharma Ab | Karbamido ciklo sutrikimų gydymo būdai |
WO2015063659A1 (en) | 2013-10-30 | 2015-05-07 | Lupin Limited | Process for the preparation of glycerol phenylbutyrate |
CN105764497A (zh) | 2013-11-14 | 2016-07-13 | 奥特吉尼克斯制药公司 | 三酸甘油酯的固体组合物及其用途 |
JP6302091B2 (ja) | 2014-04-30 | 2018-03-28 | ザ・ジョンズ・ホプキンス・ユニバーシティー | デンドリマー組成物および眼の疾患の処置におけるその使用 |
EP3180031A1 (en) | 2014-08-13 | 2017-06-21 | The Johns Hopkins University | Selective dendrimer delivery to brain tumors |
CN108430514B (zh) | 2015-10-29 | 2023-11-03 | 约翰霍普金斯大学 | 用于治疗过氧化物酶体病症和脑白质营养不良的组合物和方法 |
US9914692B2 (en) | 2016-05-25 | 2018-03-13 | Horizon Therapeutics, Llc | Procedure for the preparation of 4-phenyl butyrate and uses thereof |
US10668040B2 (en) | 2017-09-11 | 2020-06-02 | Horizon Therapeutics, Llc | Treatment of urea cycle disorders in neonates and infants |
EP4069308A2 (en) | 2019-12-04 | 2022-10-12 | Ashvattha Therapeutics, Inc. | Dendrimer compositions and methods for drug delivery to the eye |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5879657A (en) * | 1993-03-30 | 1999-03-09 | The Dupont Merck Pharmaceutical Company | Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders |
-
1996
- 1996-02-06 AU AU48587/96A patent/AU4858796A/en not_active Abandoned
- 1996-02-06 ES ES96904495T patent/ES2157422T3/es not_active Expired - Lifetime
- 1996-02-06 WO PCT/US1996/000940 patent/WO1996024571A1/en active IP Right Grant
- 1996-02-06 EP EP96904495A patent/EP0858441B1/en not_active Expired - Lifetime
- 1996-02-06 DE DE69612755T patent/DE69612755T2/de not_active Expired - Lifetime
- 1996-02-06 AT AT96904495T patent/ATE201013T1/de not_active IP Right Cessation
- 1996-02-06 CA CA2212047A patent/CA2212047C/en not_active Expired - Fee Related
-
1998
- 1998-01-13 US US09/006,432 patent/US5968979A/en not_active Expired - Lifetime
-
1999
- 1999-05-25 US US09/317,900 patent/US6083984A/en not_active Expired - Lifetime
- 1999-05-25 US US09/317,901 patent/US6060510A/en not_active Expired - Lifetime
-
2016
- 2016-02-03 FR FR16C0003C patent/FR16C0003I2/fr active Active
Also Published As
Publication number | Publication date |
---|---|
DE69612755T2 (de) | 2001-08-23 |
AU4858796A (en) | 1996-08-27 |
ATE201013T1 (de) | 2001-05-15 |
US5968979A (en) | 1999-10-19 |
EP0858441A4 (pm) | 1998-08-19 |
US6083984A (en) | 2000-07-04 |
EP0858441A1 (en) | 1998-08-19 |
CA2212047A1 (en) | 1996-08-15 |
US6060510A (en) | 2000-05-09 |
ES2157422T3 (es) | 2001-08-16 |
CA2212047C (en) | 2010-11-16 |
DE69612755D1 (de) | 2001-06-13 |
FR16C0003I2 (fr) | 2016-06-24 |
WO1996024571A1 (en) | 1996-08-15 |
EP0858441B1 (en) | 2001-05-09 |